Clinical Trials
110
Active:5
Completed:40
Trial Phases
5 Phases
Phase 1:7
Phase 2:9
Phase 3:13
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (65 trials with phase data)• Click on a phase to view related trials
Not Applicable
27 (41.5%)Phase 3
13 (20.0%)Phase 2
9 (13.8%)Phase 4
9 (13.8%)Phase 1
7 (10.8%)Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients
Not Applicable
Not yet recruiting
- Conditions
- Depressive Disorder
- Interventions
- Drug: Experimental regimenDrug: Control regimen
- First Posted Date
- 2025-09-04
- Last Posted Date
- 2025-09-04
- Target Recruit Count
- 220
- Registration Number
- NCT07153406
- Locations
- 🇪🇸
Clínica Psiquiátrica Padre Menni, Pamplona, Navarre, Spain
🇪🇸Hospital Vall d'Hebron, Barcelona, Spain
🇪🇸Hospital De La Santa Creu i Sant Pau, Barcelona, Spain
Clinical and Ecological Impact of a Primary Care Antimicrobial Stewardship Program Based on Telematic Educational Interviews (TELÉMACO Trial)
Not Applicable
Recruiting
- Conditions
- Community Acquired Infections
- First Posted Date
- 2024-11-26
- Last Posted Date
- 2024-11-26
- Target Recruit Count
- 30
- Registration Number
- NCT06706583
- Locations
- 🇪🇸
Hospital Universitario Virgen del Rocío, Sevilla, Spain
NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic Patients
Not Applicable
Completed
- Conditions
- Non-alcoholic Fatty Liver Disease (NAFLD)
- First Posted Date
- 2024-11-14
- Last Posted Date
- 2024-11-14
- Target Recruit Count
- 536
- Registration Number
- NCT06688149
- Locations
- 🇩🇪
University Hospital Düsseldorf, Düsseldorf, Germany
🇩🇪University Medical Center Mainz, Mainz, Germany
🇬🇷Harokopio University of Athens, Athens, Greece
TMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
Phase 2
Not yet recruiting
- Conditions
- Myelodysplastic SyndromesMyeloid Leukemia, Acute
- Interventions
- Drug: Total bone marrow and lymphoid irradiation/cyclophosphamide/etoposide
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Target Recruit Count
- 58
- Registration Number
- NCT06598969
- Locations
- 🇪🇸
Hospital Universitario Virgen del Rocío, Sevilla, Spain
TMLI/Fludarabine/Melphalan Conditioning for Allogeneic Transplantation in High-risk Myelodysplastic Syndrome or Acute Myeloid Leukemia.
Phase 2
Not yet recruiting
- Conditions
- Myelodysplastic SyndromesAcute Myeloid Leukemia
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Target Recruit Count
- 34
- Registration Number
- NCT06602323
- Prev
- 1
- 2
- 3
- 4
- 5
- 23
- Next
News
No news found